2m 2m 2m 2m 2m 2m 2m
Rein Therap (RNTX)
NASDAQ
$1.03+$0.01 (+0.98%)
Price as of Jun 03, 2026 7:02 PM EDT- $94.9MMarket Cap
- -49.01%1-Year Change
- BiotechnologyIndustry
Rein Therap (RNTX)
$1.03+$0.01 (+0.98%)
RNTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.02 | ||
Change | -$0.04 (-3.74%) | ||
Open | $1.01 | ||
High | $1.04 | ||
Low | $0.98 | ||
Previous Close | $1.03 | ||
Volume | 407,431 | ||
30-Day Average Volume | 911,593 | ||
1-Week Change | -3.74% | ||
1-Month Change | 0.00% | ||
1-Year Change | -49.01% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 85.5M | ||
Total Assets | $26.3M | ||
Market Cap | $94.9M | ||
Enterprise Value | $95.4M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$5.8M | ||
Free Cash Flow | -$3.4M | ||
EBIT | -$5.8M | ||
EBITDA | -$5.8M | ||
Net Working Capital | -$8.2M | ||
EPS | -$0.19 | ||
Enterprise Value/EBITDA | -16 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -6 | ||
PEG | -0 | ||
Price/Free Cash Flow | -28 | ||
Price/Operating Cash Flow | -28 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue